Reflector Bio attends AIDDD 2026
The AI Drug Discovery & Development Summit in Boston brings together leaders advancing AI applications across drug discovery and development, from early research to clinical translation.
2026
Featured
Founded by MIT and Flagship Alum, AI Drug Discovery Company Reflector Bio Emerges from Stealth
The New York techbio company's biological foundation model predicts a compound’s efficacy in cells, adding a complementary signal to structure-based tools in AI drug discovery.
Read the announcement →
Reflector Bio attends the Oncology Venture, Innovation & Partnering Summit
The summit connects investors, biotech executives, and pharmaceutical leaders to discuss oncology innovation, investment, and strategic partnerships.
Reflector Bio attends ARDD 2026
The 13th Aging Research and Drug Discovery Meeting covers advances in aging biology, longevity therapeutics, and AI-driven drug discovery.
Reflector Bio attends Decoding Bio’s AI x Bio Summit
Held at the New York Stock Exchange, the summit brings together biotech founders, investors, scientists, and pharmaceutical leaders shaping the future of AI-driven biotechnology.
Yuge Ji, PhD speaks at the AI x Longevity Summit
Reflector Bio’s Founder and CEO spoke at Longevity Global’s New York City summit exploring the intersection of artificial intelligence and longevity science.
Reflector Bio attends the AWS Life Sciences Symposium 2026
The symposium focused on applications of agentic AI, machine learning, and cloud technologies across drug discovery, clinical development, and the life sciences.
Yuge Ji, PhD speaks at NGEN’s Lab-to-Startup Conference
Reflector Bio’s Founder and CEO joined a panel discussing the role of AI in scientific research at NGEN’s Science to Scale conference in New York City.
Reflector Bio selected for the 2026 NYCEDC Founder Fellowship
Selected as one of 60 startups in the 2026 cohort, Reflector Bio joins Company Ventures’ accelerator program, providing access to mentorship, investor networks, and business development support.
2025
Yuge Ji, PhD speaks at AGENTIC 2025
Reflector Bio’s Founder and CEO joined a panel at 120/80 Health Group’s conference examining the role of AI in drug discovery, development, and the life sciences.
Reflector Bio and KiraGen Bio collaborate to advance AI-guided multiplex gene editing for cell therapy
The collaboration combines Reflector Bio’s pretrained Phenomena model with KiraGen’s KiraLOGIC platform to prioritize gene-edit combinations for solid-tumor cell therapy.
Reflector Bio attends BIO International Convention 2025
The annual convention in Boston brought together biotechnology and pharmaceutical leaders, investors, and researchers for scientific exchange, industry partnering, and business development.
Reflector Bio’s technology used in the Cancer Plasticity Atlas
The initiative combines large-scale organoid perturbation experiments with AI to understand cancer cell plasticity and predict responses to therapy.